JP2024510503A5 - - Google Patents
Info
- Publication number
- JP2024510503A5 JP2024510503A5 JP2023557352A JP2023557352A JP2024510503A5 JP 2024510503 A5 JP2024510503 A5 JP 2024510503A5 JP 2023557352 A JP2023557352 A JP 2023557352A JP 2023557352 A JP2023557352 A JP 2023557352A JP 2024510503 A5 JP2024510503 A5 JP 2024510503A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162477P | 2021-03-17 | 2021-03-17 | |
| US63/162,477 | 2021-03-17 | ||
| PCT/US2022/020479 WO2022197756A1 (en) | 2021-03-17 | 2022-03-16 | Plasma kallikrein inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024510503A JP2024510503A (ja) | 2024-03-07 |
| JP2024510503A5 true JP2024510503A5 (https=) | 2025-03-24 |
| JPWO2022197756A5 JPWO2022197756A5 (https=) | 2025-03-24 |
Family
ID=81327137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557352A Pending JP2024510503A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレイン阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240382482A1 (https=) |
| EP (1) | EP4308228A1 (https=) |
| JP (1) | JP2024510503A (https=) |
| CN (1) | CN117396474A (https=) |
| WO (1) | WO2022197756A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200143376A (ko) | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| CN114667289B (zh) | 2019-09-18 | 2025-08-26 | 武田药品工业有限公司 | 杂芳基血浆激肽释放酶抑制剂 |
| EP4031547B1 (en) | 2019-09-18 | 2024-07-17 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof |
| CN117396473A (zh) * | 2021-03-17 | 2024-01-12 | 武田药品工业株式会社 | 血浆激肽释放酶的咪唑并吡啶基抑制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6887870B1 (en) * | 1999-10-12 | 2005-05-03 | Bristol-Myers Squibb Company | Heterocyclic sodium/proton exchange inhibitors and method |
| AU2008309517B2 (en) * | 2007-10-12 | 2013-03-14 | Astrazeneca Ab | Inhibitors of protein kinases |
| EP2627178B1 (en) * | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
| EP3087067B1 (en) * | 2013-12-26 | 2018-10-24 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors |
| CN106794181A (zh) * | 2014-06-04 | 2017-05-31 | 托马斯·黑勒戴药物研究基金会 | 用于治疗炎性和自身免疫性病况的mth1抑制剂 |
| WO2016010108A1 (ja) * | 2014-07-18 | 2016-01-21 | 塩野義製薬株式会社 | 含窒素複素環誘導体およびそれらを含有する医薬組成物 |
| WO2016201052A1 (en) | 2015-06-12 | 2016-12-15 | Global Blood Therapeutics, Inc. | Bridged bicyclic kallikrein inhibitors |
| IL263235B (en) | 2016-05-31 | 2022-07-01 | Kalvista Pharmaceuticals Ltd | History of pyrazoles as plasma kallikrein inhibitors |
| KR20200143376A (ko) * | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
-
2022
- 2022-03-16 US US18/550,571 patent/US20240382482A1/en active Pending
- 2022-03-16 EP EP22714694.1A patent/EP4308228A1/en active Pending
- 2022-03-16 CN CN202280033916.XA patent/CN117396474A/zh active Pending
- 2022-03-16 WO PCT/US2022/020479 patent/WO2022197756A1/en not_active Ceased
- 2022-03-16 JP JP2023557352A patent/JP2024510503A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510503A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2025004149A1 (es) | Método y sistema para la recuperación de elementos valiosos a partir de la materia prima derivada de los relaves de minas de cobre. | |
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307049990S (https=) | ||
| CN307046488S (https=) | ||
| BY13157U (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) | ||
| CN307044824S (https=) |